Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
<h4>Background</h4>Xpert MTB/RIF (Xpert) is a promising new rapid diagnostic technology for tuberculosis (TB) that has characteristics that suggest large-scale roll-out. However, because the test is expensive, there are concerns among TB program managers and policy makers regarding its a...
Guardado en:
Autores principales: | Anna Vassall, Sanne van Kampen, Hojoon Sohn, Joy S Michael, K R John, Saskia den Boon, J Lucian Davis, Andrew Whitelaw, Mark P Nicol, Maria Tarcela Gler, Anar Khaliqov, Carlos Zamudio, Mark D Perkins, Catharina C Boehme, Frank Cobelens |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3ef06466a6544ef8fc3efe2db318af2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
por: T. Kedia, et al.
Publicado: (2015) -
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
por: Neeraj Raizada, et al.
Publicado: (2014) -
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
por: Andrea Rachow, et al.
Publicado: (2011) -
Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
por: Han Na Lee, et al.
Publicado: (2021) -
Ensayo Xpert MTB/RIF en el diagnóstico de tuberculosis
por: VALLEJO V,PATRICIO, et al.
Publicado: (2015)